Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Buccal Respiratory Chain Complexes I and IV Quantities in Huntington's Disease Patients.

Dušek P, Rodinová M, Lišková I, Klempíř J, Zeman J, Roth J, Hansíková H.

Folia Biol (Praha). 2018;64(1):31-34.

2.

Clinical correlates of mitochondrial function in Huntington's disease muscle.

Turner C, Cooper JM, Schapira AH.

Mov Disord. 2007 Sep 15;22(12):1715-21.

PMID:
17557337
3.

Normal platelet mitochondrial complex I activity in Huntington's disease.

Powers WJ, Haas RH, Le T, Videen TO, Hershey T, McGee-Minnich L, Perlmutter JS.

Neurobiol Dis. 2007 Jul;27(1):99-101. Epub 2007 May 5.

4.

Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers.

Silva AC, Almeida S, Laço M, Duarte AI, Domingues J, Oliveira CR, Januário C, Rego AC.

Mitochondrion. 2013 Nov;13(6):801-9. doi: 10.1016/j.mito.2013.05.006. Epub 2013 May 23.

PMID:
23707479
5.

Non-invasive evaluation of buccal respiratory chain enzyme dysfunction in mitochondrial disease: comparison with studies in muscle biopsy.

Goldenthal MJ, Kuruvilla T, Damle S, Salganicoff L, Sheth S, Shah N, Marks H, Khurana D, Valencia I, Legido A.

Mol Genet Metab. 2012 Mar;105(3):457-62. doi: 10.1016/j.ymgme.2011.11.193. Epub 2011 Nov 30.

PMID:
22189081
6.

Biochemical abnormalities and excitotoxicity in Huntington's disease brain.

Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH.

Ann Neurol. 1999 Jan;45(1):25-32.

PMID:
9894873
7.

Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.

Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH.

Hum Mol Genet. 2011 Apr 1;20(7):1438-55. doi: 10.1093/hmg/ddr024. Epub 2011 Jan 21.

8.

Non-invasive screening of cytochrome c oxidase deficiency in children using a dipstick immunocapture assay.

Rodinová M, Trefilová E, Honzík T, Tesařová M, Zeman J, Hansíková H.

Folia Biol (Praha). 2014;60(6):268-74.

9.

Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.

Kumar P, Kumar A.

Behav Brain Res. 2010 Jan 5;206(1):38-46. doi: 10.1016/j.bbr.2009.08.028. Epub 2009 Aug 27.

PMID:
19716383
10.

Mitochondrial dynamics and quality control in Huntington's disease.

Guedes-Dias P, Pinho BR, Soares TR, de Proença J, Duchen MR, Oliveira JM.

Neurobiol Dis. 2016 Jun;90:51-7. doi: 10.1016/j.nbd.2015.09.008. Epub 2015 Sep 24. Review.

PMID:
26388396
11.

Regional mitochondrial respiratory activity in Huntington's disease brain.

Brennan WA Jr, Bird ED, Aprille JR.

J Neurochem. 1985 Jun;44(6):1948-50.

PMID:
2985766
12.

Exercise training normalizes mitochondrial respiratory capacity within the striatum of the R6/1 model of Huntington's disease.

Herbst EA, Holloway GP.

Neuroscience. 2015 Sep 10;303:515-23. doi: 10.1016/j.neuroscience.2015.07.025. Epub 2015 Jul 14.

PMID:
26186895
13.

Mitochondrial-dependent apoptosis in Huntington's disease human cybrids.

Ferreira IL, Nascimento MV, Ribeiro M, Almeida S, Cardoso SM, Grazina M, Pratas J, Santos MJ, Januário C, Oliveira CR, Rego AC.

Exp Neurol. 2010 Apr;222(2):243-55. doi: 10.1016/j.expneurol.2010.01.002. Epub 2010 Jan 14.

PMID:
20079354
14.

Complex I defect in muscle from patients with Huntington's disease.

Arenas J, Campos Y, Ribacoba R, Martín MA, Rubio JC, Ablanedo P, Cabello A.

Ann Neurol. 1998 Mar;43(3):397-400.

PMID:
9506560
15.

S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.

Haun F, Nakamura T, Shiu AD, Cho DH, Tsunemi T, Holland EA, La Spada AR, Lipton SA.

Antioxid Redox Signal. 2013 Oct 10;19(11):1173-84. doi: 10.1089/ars.2012.4928. Epub 2013 Jun 20.

16.

Impaired mitochondrial trafficking in Huntington's disease.

Li XJ, Orr AL, Li S.

Biochim Biophys Acta. 2010 Jan;1802(1):62-5. doi: 10.1016/j.bbadis.2009.06.008. Epub 2009 Jul 8. Review.

17.

Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease.

Feldhaus P, Fraga DB, Ghedim FV, De Luca RD, Bruna TD, Heluany M, Matos MP, Ferreira GK, Jeremias IC, Heluany C, Streck EL, Zugno AI.

Metab Brain Dis. 2011 Sep;26(3):229-36. doi: 10.1007/s11011-011-9253-y. Epub 2011 Jul 26.

PMID:
21789567
18.

Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.

Clemens LE, Weber JJ, Wlodkowski TT, Yu-Taeger L, Michaud M, Calaminus C, Eckert SH, Gaca J, Weiss A, Magg JC, Jansson EK, Eckert GP, Pichler BJ, Bordet T, Pruss RM, Riess O, Nguyen HP.

Brain. 2015 Dec;138(Pt 12):3632-53. doi: 10.1093/brain/awv290. Epub 2015 Oct 21.

PMID:
26490331
19.

Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease.

Kasparová S, Sumbalová Z, Bystrický P, Kucharská J, Liptaj T, Mlynárik V, Gvozdjáková A.

Neurochem Int. 2006 Jan;48(2):93-9. Epub 2005 Nov 14.

PMID:
16290265
20.

Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.

Liu W, Chaurette J, Pfister EL, Kennington LA, Chase KO, Bullock J, Vonsattel JP, Faull RL, Macdonald D, DiFiglia M, Zamore PD, Aronin N.

J Huntingtons Dis. 2013;2(4):491-500. doi: 10.3233/JHD-130079.

PMID:
25062733

Supplemental Content

Support Center